Adverse health effects of marijuana use.
作者信息
Volkow Nora D, Baler Ruben D, Compton Wilson M, Weiss Susan R B
机构信息
From the National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD.
出版信息
N Engl J Med. 2014 Jun 5;370(23):2219-27. doi: 10.1056/NEJMra1402309.
Abstract
摘要
相似文献
1
Adverse health effects of marijuana use.
N Engl J Med. 2014 Jun 5;370(23):2219-27. doi: 10.1056/NEJMra1402309.
2
The cannabis experiment.
Nature. 2015 Aug 20;524(7565):280-3. doi: 10.1038/524280a.
3
Recreational cannabinoid use: The hazards behind the "high".
J Fam Pract. 2016 Nov;65(11):770-779.
4
[Adverse effects of marijuana].
Rev Prat. 2005 Jan 15;55(1):41-9.
5
Adverse health effects of non-medical cannabis use.
Lancet. 2009 Oct 17;374(9698):1383-91. doi: 10.1016/S0140-6736(09)61037-0.
6
[Does stronger cannabis cause more health problems?].
Tidsskr Nor Laegeforen. 2016 Nov 8;136(20):1736-1738. doi: 10.4045/tidsskr.15.1297. eCollection 2016 Nov.
7
Recreational Cannabis - Minimizing the Health Risks from Legalization.
N Engl J Med. 2017 Feb 23;376(8):705-707. doi: 10.1056/NEJMp1614783.
8
Young brains on drugs.
Science. 2014 May 9;344(6184):557. doi: 10.1126/science.1254989.
9
The adverse health effects of chronic cannabis use.
Drug Test Anal. 2014 Jan-Feb;6(1-2):39-45. doi: 10.1002/dta.1506. Epub 2013 Jul 8.
10
Marijuana gears up for production high in US labs.
Nature. 2015 Mar 19;519(7543):269-70. doi: 10.1038/519269a.
引用本文的文献
1
Pre-employment urine drug screening: examining trends in THC-COOH positivity rates post-legalization of recreational cannabis in California - a retrospective review.
J Occup Med Toxicol. 2025 Sep 8;20(1):29. doi: 10.1186/s12995-025-00468-3.
2
A Meta-Analysis of Bi-Directional Associations between Sleep Health and Substance Use among U.S. Youth: Racial/Ethnic Differences.
Curr Addict Rep. 2025 Dec;12(1). doi: 10.1007/s40429-025-00628-9. Epub 2025 Feb 24.
3
Regular cannabis use and promotive attitudes among diverse adolescents in the United States: The role of age and intersecting social positions.
Drug Alcohol Depend. 2025 Aug 22;276:112851. doi: 10.1016/j.drugalcdep.2025.112851.
4
Cannabis: What We Use, Why It Matters, and When It Is Prescribed (Ethics, Policy, and Practice).
Cureus. 2025 Jul 30;17(7):e89073. doi: 10.7759/cureus.89073. eCollection 2025 Jul.
5
Daily Cannabis Use: Do Impulsivity and Sensation Seeking Predict Negative Cannabis Related Consequences?
J Drug Issues. 2025 Jul;55(3). doi: 10.1177/00220426231226221. Epub 2024 Jan 4.
6
Medical and recreational cannabis use in patients undergoing one- or two-level lumbar spine fusion correlated with postoperative outcomes.
N Am Spine Soc J. 2025 Jul 18;23:100773. doi: 10.1016/j.xnsj.2025.100773. eCollection 2025 Sep.
7
Large-Scale Profiling of Coding and Long Noncoding Transcriptomes in the Hippocampus of Mice Acutely Exposed to Vaporized CBD or THC.
Int J Mol Sci. 2025 Jul 23;26(15):7106. doi: 10.3390/ijms26157106.
8
Neural Circuit Mapping and Neurotherapy-Based Strategies.
Cell Mol Neurobiol. 2025 Jul 26;45(1):75. doi: 10.1007/s10571-025-01595-5.
9
Cognitive Effects of Cannabis Use: A Comprehensive Review Across Domains.
Neurol Int. 2025 Jul 15;17(7):107. doi: 10.3390/neurolint17070107.
10
Cannabis legalization and cannabis use disorder in United States Veterans Health Administration patients with and without psychiatric disorders, 2005-2022: a repeated cross-sectional study.
Lancet Reg Health Am. 2025 Jun 28;48:101155. doi: 10.1016/j.lana.2025.101155. eCollection 2025 Aug.
本文引用的文献
1
Targeting the cannabinoid system for pain relief?
Acta Anaesthesiol Taiwan. 2013 Dec;51(4):161-70. doi: 10.1016/j.aat.2013.10.004. Epub 2013 Dec 25.
2
Trends in alcohol and other drugs detected in fatally injured drivers in the United States, 1999-2010.
Am J Epidemiol. 2014 Mar 15;179(6):692-9. doi: 10.1093/aje/kwt327. Epub 2014 Jan 29.
3
Miswiring the brain: Δ9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway.
EMBO J. 2014 Apr 1;33(7):668-85. doi: 10.1002/embj.201386035. Epub 2014 Jan 27.
4
Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users.
Schizophr Bull. 2014 Nov;40(6):1509-17. doi: 10.1093/schbul/sbt181. Epub 2013 Dec 17.
5
Vascular targets for cannabinoids: animal and human studies.
Br J Pharmacol. 2014 Mar;171(6):1361-78. doi: 10.1111/bph.12560.
6
Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy.
Epilepsy Behav. 2013 Dec;29(3):574-7. doi: 10.1016/j.yebeh.2013.08.037.
7
Functional connectivity in inhibitory control networks and severity of cannabis use disorder.
Am J Drug Alcohol Abuse. 2013 Nov;39(6):382-91. doi: 10.3109/00952990.2013.841710.
8
Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know.
Am J Cardiol. 2014 Jan 1;113(1):187-90. doi: 10.1016/j.amjcard.2013.09.042. Epub 2013 Oct 5.
9
Is the relationship between early-onset cannabis use and educational attainment causal or due to common liability?
Drug Alcohol Depend. 2013 Dec 1;133(2):580-6. doi: 10.1016/j.drugalcdep.2013.07.034. Epub 2013 Aug 11.
10
Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism.
Br J Pharmacol. 2013 Oct;170(3):679-92. doi: 10.1111/bph.12321.
Zotero 插件